These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2701308)

  • 41. Precipitated withdrawal by pentazocine in methadone-maintained volunteers.
    Strain EC; Preston KL; Liebson IA; Bigelow GE
    J Pharmacol Exp Ther; 1993 Nov; 267(2):624-34. PubMed ID: 7504098
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acute physical dependence in man: effects of naloxone after brief morphine exposure.
    Bickel WK; Stitzer ML; Liebson IA; Bigelow GE
    J Pharmacol Exp Ther; 1988 Jan; 244(1):126-32. PubMed ID: 3335995
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Withdrawal from heroin and methadone.
    Travers R
    Br J Psychiatry; 1991 Oct; 159():582-3. PubMed ID: 1751876
    [No Abstract]   [Full Text] [Related]  

  • 44. [Methadone and sleep apnea syndrome].
    Durst P; Palazzolo J; Peyrelong JP; Berger M; Chalabreysse M; Billiard M; Vialle A
    Can J Psychiatry; 2005 Mar; 50(3):153-8. PubMed ID: 15830825
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Technique for greatly shortening the transition from methadone to naltrexone maintenance of patients addicted to opiates.
    Loimer N; Lenz K; Schmid R; Presslich O
    Am J Psychiatry; 1991 Jul; 148(7):933-5. PubMed ID: 2053636
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Opiate withdrawal.
    Farrell M
    Addiction; 1994 Nov; 89(11):1471-5. PubMed ID: 7841858
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Metyrapone-induced withdrawal symptoms: symptoms in methadone-maintained patients.
    Kennedy JA; Hartman N; Sbriglio R; Khuri E; Albeck H; Kreek MJ
    NIDA Res Monogr; 1990; 105():416. PubMed ID: 1876057
    [No Abstract]   [Full Text] [Related]  

  • 48. Naloxone applied to conjunctiva as a test for physical opiate dependence.
    Creighton FJ; Ghodse AH
    Lancet; 1989 Apr; 1(8641):748-50. PubMed ID: 2564564
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of sublingually given naloxone in opioid-dependent human volunteers.
    Preston KL; Bigelow GE; Liebson IA
    Drug Alcohol Depend; 1990 Feb; 25(1):27-34. PubMed ID: 2323306
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Letter: Naloxone for diagnosis in methadone programs.
    Blachly PH
    Clin Pharmacol Ther; 1975 Feb; 17(2):251. PubMed ID: 1091394
    [No Abstract]   [Full Text] [Related]  

  • 51. Opiate dependence and withdrawal: preliminary assessment using single photon emission computerized tomography (SPECT).
    Krystal JH; Woods SW; Kosten TR; Rosen MI; Seibyl JP; van Dyck CC; Price LH; Zubal IG; Hoffer PB; Charney DS
    Am J Drug Alcohol Abuse; 1995 Feb; 21(1):47-63. PubMed ID: 7762544
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rapid detoxification from opioid dependence.
    Kosten TR; Krystal JH; Charney DS; Price LH; Morgan CH; Kleber HD
    Am J Psychiatry; 1989 Oct; 146(10):1349. PubMed ID: 2675644
    [No Abstract]   [Full Text] [Related]  

  • 53. Combined naloxone/methadone preparations for opiate substitution therapy.
    Loimer N; Presslich O; Grünberger J; Linzmayer L
    J Subst Abuse Treat; 1991; 8(3):157-60. PubMed ID: 1960767
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dose dependent effects of yohimbine on methadone maintained patients.
    Hameedi FA; Woods SW; Rosen MI; Pearsall HR; Kosten TR
    Am J Drug Alcohol Abuse; 1997 May; 23(2):327-33. PubMed ID: 9143642
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [No opiates against cannabis hyperemesis syndrome].
    Bonnet U; Stratmann U; Isbruch K
    Dtsch Med Wochenschr; 2014 Feb; 139(8):375-7. PubMed ID: 24519114
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Continuous naloxone administration suppresses opiate withdrawal symptoms in human opiate addicts during detoxification treatment.
    Loimer N; Schmid RW; Presslich O; Lenz K
    J Psychiatr Res; 1989; 23(1):81-6. PubMed ID: 2547057
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acute blocking of naloxone-precipitated opiate withdrawal symptoms by methohexitone.
    Loimer N; Schmid R; Lenz K; Presslich O; Grünberger J
    Br J Psychiatry; 1990 Nov; 157():748-52. PubMed ID: 2279212
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Severity of precipitated opiate withdrawal predicts drug dependence by DSM-III-R criteria.
    Kosten TA; Jacobsen LK; Kosten TR
    Am J Drug Alcohol Abuse; 1989; 15(3):237-50. PubMed ID: 2763981
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ophthalmic naloxone elicits abstinence in opioid-dependent subjects.
    Sanchez-Ramos JR; Senay EC
    Br J Addict; 1987 Mar; 82(3):313-5. PubMed ID: 3471262
    [No Abstract]   [Full Text] [Related]  

  • 60. Prevalence and diagnostic reliability of methadone maintenance detoxification fear.
    Milby JB; Gurwitch RH; Wiebe DJ; Ling W; McLellan AT; Woody GE
    Am J Psychiatry; 1986 Jun; 143(6):739-43. PubMed ID: 3717396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.